Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir ± peginterferon alfa-2a + ribavirin in chronic HCV (China)
CTR20150250Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sofosbuvir in hepatitis C virus infection, sponsored by Gilead Sciences. Started Jul 2015; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on CTR20150250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150250.